Vertex Pharmaceuticals
VRTX
VRTX
480 hedge funds and large institutions have $20.6B invested in Vertex Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 204 increasing their positions, 161 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
480
Holders Change
-20
Holders Change %
-4%
% of All Funds
12.83%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
47
Increased
204
Reduced
161
Closed
61
Calls
$81.8M
Puts
$81.3M
Net Calls
+$494K
Net Calls Change
+$12.1M
Top Buyers
Top Sellers
1 |
Royal London Asset Management
United Kingdom
|
-$397M |
2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$151M |
3 |
Two Sigma Investments
New York
|
-$79.1M |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$66.7M |
5 |
Goldman Sachs
New York
|
-$66.5M |